News Quantified


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Penumbra (NYSE:PEN) had its "hold (c+)" rating reaffirmed by analysts at Weiss Ratings.

Penumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference

Penumbra (NYSE:PEN) is now covered by analysts at Wells Fargo & Company. They set an "underweight" rating and a $15.00 price target on the stock.

Penumbra Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand [Yahoo! Finance]

Penumbra (NYSE:PEN) had its price target raised by analysts at JPMorgan Chase & Co. from $265.00 to $275.00. They now have a "neutral" rating on the stock.

11/5/2025

04:05 pm

PEN

17.3%

BEAT

7/29/2025

04:05 pm

PEN

11.9%

BEAT

4/23/2025

04:05 pm

PEN

7.0%

BEAT

2/18/2025

04:05 pm

PEN

12.0%

BEAT

Wells Fargo & Company

Form 4 Penumbra Inc For: Dec 01 Filed by: Roberts Johanna

Form 4 Penumbra Inc For: Dec 02 Filed by: Grewal Harpreet

Form 144 Penumbra Inc Filed by: Grewal Harpreet

Form 4 Penumbra Inc For: Nov 25 Filed by: Roberts Johanna

Form 4 Penumbra Inc For: Nov 25 Filed by: Bose Arani

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}